Linagliptin Inhibits Lipopolysaccharide-Induced Inflammation Concentration-Dependently And -Independently

Naoki Sato,1,2 Yuya Nakamura,1,3 Shiho Yamadera,4 Masahiro Inagaki,1,5 Sachiyo Kenmotsu,5 Hiroshi Saito,4,6 Tatsunori Oguchi,1 Mayumi Tsuji,1 Hirokazu Chokki,1 Isao Ohsawa,3 Hiromichi Gotoh,3 Shinichi Iwai,6 Yuji Kiuchi1 1Department of Pharmacology, Showa University School of Medicine, Shinagawa-ku,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sato N, Nakamura Y, Yamadera S, Inagaki M, Kenmotsu S, Saito H, Oguchi T, Tsuji M, Chokki H, Ohsawa I, Gotoh H, Iwai S, Kiuchi Y
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	linagliptin lipopolysaccharide lipopolysaccharide-binding protein interleukin-6 intranuclear subunit of nuclear factor-κB/p65 intracellular reactive oxygen species Pathology RB1-214 Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/71a3fb4bd53e4f08ac724daa0c043192
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Linagliptin Inhibits Lipopolysaccharide-Induced Inflammation Concentration-Dependently And -Independently

Ejemplares similares